Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

NCT01005654 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01005654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01005654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
October 7, 2009
Completion date
Not reported
Enrollment
2,415 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal neoplasm, endocrine tumors, neuroblastoma, parathyroid neoplasms, thyroid neoplasms